Skip to content
All research

Sustainable Finance

The ESG Advantage

Forging resilience and value at RPG Life Sciences

Domain
Sustainable Finance
Kind
Independent research
Length
14 pp · 15 MB

What it found

+707%
share performance against peers
₹5.65 Cr
annual carbon-tax exposure quantified
The ESG Advantage, first page

Overview

An ESG value case on a listed Indian pharma compounding +707% against peers while macro carbon pressure rises: quantifies a ₹5.65 Cr annual carbon-tax exposure, maps strategic materiality, and frames how to decouple financial performance from environmental impact.